Examen de la legislación de aplicación del Acuerdo sobre los ADPIC - Búsqueda

Restablecer
 
 

En el párrafo 2 del artículo 63 del Acuerdo sobre los ADPIC, se exige a los Miembros que notifiquen al Consejo de los ADPIC las leyes y los reglamentos hechos efectivos por el Miembro en cuestión y referentes a la materia del Acuerdo, con el fin de ayudar al Consejo en su examen de la aplicación del Acuerdo.

En esta página puede hacer búsquedas en las preguntas y respuestas de los Miembros sobre las leyes y los reglamentos notificados. Puede consultar los resultados de la búsqueda en la pantalla, descargarlos en formato Excel e imprimirlos. También puede descargar los distintos documentos.

* NO es necesario utilizar todos los campos de búsqueda que figuran a continuación (rellene solo los que sean pertinentes para su consulta).
* Tenga en cuenta que los criterios de búsqueda utilizados son acumulativos. Todos se reflejarán en los resultados de la búsqueda.


Página 669 de 677   |   Número de documentos : 13533

Signatura del documento Miembro que presenta la notificación Miembro que plantea la pregunta Pregunta Respuesta Fecha de distribución del documento  
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 27. Please explain whether or not plants, animals and essentially biological processes are excluded from patentability in your legislation. If so, please explain the relevant section of your legislation and explain its formulation.
At present, plants, animals and essentially biological processes are not excluded from patentability in Fiji's legislation.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 28. Please describe how micro-organisms, non-essentially biological processes, microbiological processes and plant varieties are protected in your legislation. Please explain, in this respect, the relevant sections of your legislation.
At present, micro-organisms, non-essentially biological processes, microbiological processes and plant varieties are not protected in the current legislation.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 29. Please explain how your legislation protects patent right holders against the importing and against the offering for sale of a patented invention.
At present, there are no provision for protection of rights holders against the importing and against the offering for sale of a patented invention.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 30. Please state if your legislation provides for patent product protection of pharmaceutical and agricultural chemical products. In the affirmative, please indicate the legal reference.
At present, the Patents Act does not provide protection of pharmaceutical and agricultural chemical products. In fact, section 3A provides that pharmaceutical products and substances are exceptions to infringement of patent rights.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 31. Please clarify if the patent protection of a process, as provided for in your legislation, covers the product obtained directly by that process.
The legislation does not cover the patent protection of a process or the product obtained directly by that process.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 32. Please explain the additional conditions, if any, in your legislation other than the sufficient disclosure of the invention in Article 29 of the TRIPS Agreement (e.g. submission of justification for access to genetic material or prior inform consent to its use). If such additional conditions exist, please point out the relevant legislations and describe the additional conditions in detail.
There are no additional conditions other than the sufficient disclosure required in making the petition for a letters patent.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 33. Please describe if your legislation provides for limited exceptions to the exclusive rights conferred by a patent. If affirmative, please make a reference to relevant legislation.
As stated above, Section 3A provides that "it is not an infringement of patents in pharmaceuticals for any person to make, construct, use or sell the patented invention in respect of a pharmaceutical product or substance, solely for uses reasonably related to the development and submission of information required under any law of the Fiji Islands or of another country that regulates the manufacture, construction, use or sale of such pharmaceutical product or substance."
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 34. Please explain whether or not your legislation provides for compulsory licensing. If so, please explain in detail the conditions under which a compulsory licence may be granted. In particular, please explain how your national legislation considers individual merits in the authorization of such use.
At present, the Patents Act does not provide for compulsory licensing.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 35. Please explain how your legislation explicitly ensures that a proposed user has made efforts to obtain authorization from the right holder on reasonable commercial terms and conditions and that such efforts have not been successful within a reasonable period of time. In this context, how do you define "reasonable period of time". Please also explain how your legislation ensures that the use of a compulsory licence shall be authorised predominantly for the supply to the domestic market of the Member authorizing such use.
At present, the Patents Act does not provide for a proposed user to obtain authorization from a right holder.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 36. Please state if your legislation grants additional protection for innovations after the 20 years of patent protection has lapsed.
At present, Section 4 of the Patents Act only allows 14 years of patent protection and there are no additional protections after this period has lapsed.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 37. Please explain how your legislation provides for the enhanced patent protection of patents or patent applications pending on 1st January 1995.
The Patents Act does not provide for enhanced protection of patents or patent applications pending on 01/01/1995.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 38. Please explain how your legislation provides for the reversal of the burden of proof in relation to process patents.
The Patents Act does not provide for the reversal of burden of proof.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 39. Please describe how your legislation protects Topographies.
Response to Questions 39 to 42). At present, the legislation does not provide for topographies.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 40. Please explain what protection your national legislation grants to right holders against the unlawful importation, sale or distribution for commercial purposes of topographies including integrated circuits or other articles in which a topography is incorporated in accordance with Article 36 of the TRIPS Agreement.
Response to Questions 39 to 42). At present, the legislation does not provide for topographies.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 42. Please state the term of protection granted by your legislation to topographies.
Response to Questions 39 to 42). At present, the legislation does not provide for topographies.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 41. Please explain how your legislation provides for the derogation from Article 36 as specified in Article 37 of the TRIPS Agreement where a person has no knowledge or reasonable grounds to know when acquiring an integrated circuit or an article incorporating such an integrated circuit that it contains an unlawful topography.
Response to Questions 39 to 42). At present, the legislation does not provide for topographies.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 43. Please explain whether or not your legislation grants a defined period of time for the protection of undisclosed information. If so, please give the time span.
(Response to Questions 43 and 44). At present, the legislation does not address protection of undisclosed information
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 44. Please explain how your legislation defines undisclosed information.
(Response to Questions 43 and 44). At present, the legislation does not address protection of undisclosed information
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 45. Please explain how your legislation defines data submitted to governments or governmental agencies.
While sections 58 to 61 of the Copyright Act prescribe the use of copyright material by the State, rights of third parties in respect of State use, proceedings against the State, and Acts done under statutory authority, at present the legislation does not define data submitted to governments or governmental authorities.
20/05/2016
IP/Q3/FJI/1, IP/Q/FJI/1, IP/Q2/FJI/1, IP/Q4/FJI/1 Fiji Unión Europea 46. Please describe how your legislation provides for effective action against infringement of intellectual property rights.
Pursuant to section 109 of the Trade-marks Act, an infringement of copyright is actionable by the copyright owner. Reliefs are obtained by way of damages, injunctions, accounts, or otherwise is available to the plaintiff as is available in respect of the infringement of any other property right. Furthermore, section 111 prescribes delivery up in civil proceedings if a person has possession, custody or control of an object specifically designed or adapted for making copies of a copyright work and that object has been used or is to be used to make infringing copies. In addition, section 112 allows the copyright holder or a person authorized by the copyright owner to seize and detain an infringing copy of a work which is found exposed or otherwise immediately available for sale or hire. Section 113 extends the rights of exclusive licensee's the same right and remedies under sections 109, 110, 111 and 112, after the grant of a license, as if the license were an assignment. Please note that under the Patents Act, infringement action can only be brought to the high court for UK patents
20/05/2016

Página 669 de 677   |   Número de documentos : 13533

 
Restablecer